Alnylam Pharmaceuticals Reports Second Quarter 2011 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter 2011, and company highlights.
MORE ON THIS TOPIC